DSM — Koninklijke DSM NV Income Statement
0.000.00%
Last trade - 00:00
- €19.74bn
- €20.03bn
- €8.39bn
- 86
- 21
- 20
- 35
2018 December 31st | R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,267 | 7,998 | 8,106 | 7,269 | 8,390 |
Cost of Revenue | |||||
Gross Profit | 3,405 | 2,764 | 2,776 | 2,612 | 2,690 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,022 | 7,126 | 7,444 | 6,558 | 7,708 |
Operating Profit | 1,245 | 872 | 662 | 711 | 682 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,144 | 780 | 595 | 611 | 594 |
Provision for Income Taxes | |||||
Net Income After Taxes | 958 | 638 | 492 | 488 | 470 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,077 | 758 | 506 | 1,676 | 1,700 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,069 | 750 | 499 | 1,670 | 1,694 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.69 | 4.61 | 4.88 | 5.36 | 2.97 |
Dividends per Share |